Does Treatment of Hepatitis C Reduce Inhibitor Titers in Hemophilia A?

References (7)

1. Ljung RCR. How I manage patients with inherited haemophilia A and B and factor inhibitors. Br J Haematol 2018;180:501-510
2. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003;9:418-435
3. Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, Carcao M, Mahlangu J, Ragni MV, Windyga J, Llinás A, Goddard NJ, Mohan R, Poonnoose PM, Feldman BM, Lewis SZ, van den Berg HM, Pierce GF; WFH Guidelines for the Management of Hemophilia Panelists and CoAuthors. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 2020;26:1-158
4. Martins ML, Chaves DG, da Silva-Malta MCF, Bolina-Santos E, BarbosaStancioli EF, Carmo RA. Hepatitis C and history of FVIII inhibitor development in a long-term cohort of Brazilian patients with haemophilia A. Haemophilia 2020;26:130-133
5. Bolina-Santos E, Chaves DG, da Silva-Malta MCF, Carmo RA, BarbosaStancioli EF, Lobato Martins M. HCV infection in hemophilia A patients is associated with altered cytokines and chemokines profile and might modulate the levels of FVIII inhibitor. J Med Virol 2022;94:683-691
6. Holmes JA, Thompson AJ. Interferon-free combination therapies for the treatment of hepatitis C: current insights. Hepat Med 2015;7:51-70
7. Singh G, Sass R, Alamiry R, Zein N, Alkhouri N. Hepatitis C treatment with triple therapy in a patient with hemophilia A. World J Clin Cases 2013;16:106-107.